Overview

  • Product nameAnti-HLA D+DR+DQ antibody [35]
  • Description
    Mouse monoclonal [35] to HLA D+DR+DQ
  • Tested applicationsSuitable for: IP, Flow Cyt, IHC-Frmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Tumour fragments created by injecting VLM cells, (syngeneic simian virus 40 (SV40)-transformed cell line) into a BALB/c mouse.

  • General notesRecommended growth conditions: DMEM 5% FCS

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: None
    Constituents: PBS
  • Concentration information loading...
  • PurityIgG fraction
  • ClonalityMonoclonal
  • Clone number35
  • Myelomaunknown
  • IsotypeIgG3
  • Light chain typeunknown
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab20177 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IP Use at an assay dependent concentration.
Flow Cyt Use at an assay dependent concentration. ab91537-Mouse monoclonal IgG3, is suitable for use as an isotype control with this antibody.
IHC-Fr Use at an assay dependent concentration.

Target

References for Anti-HLA D+DR+DQ antibody [35] (ab20177)

This product has been referenced in:
  • Allen CA & Hogg N Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes. Cancer Res 47:2919-23 (1987). Read more (PubMed: 3105871) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab20177.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"